[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling
- PMID: 39092570
- PMCID: PMC11304389
- DOI: 10.3892/or.2024.8785
[Retracted] lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling
Abstract
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the western blotting data shown in Fig. 4B and C on p. 1952, and the Transwell invasion assay data in Fig. 2F and 4I, had already appeared in previously published articles written by different authors at different research institutes (a number of which have been retracted). Owing to the fact that the contentious data in the above article had already been published prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 42: 1946‑1956, 2019; DOI: 10.3892/or.2019.7302].
Keywords: C-C motif chemokine ligand 20; C-C motif chemokine receptor 6; ERK; long non-coding RNA-u50535; lung cancer.
Retraction of
-
lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.Oncol Rep. 2019 Nov;42(5):1946-1956. doi: 10.3892/or.2019.7302. Epub 2019 Sep 5. Oncol Rep. 2019. Retraction in: Oncol Rep. 2024 Oct;52(4):126. doi: 10.3892/or.2024.8785. PMID: 31545478 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
